News
FDA gives AbbVie's c-Met lung cancer ADC a breakthrough tag
The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status.
